Logo Image
CME
Endorsed By

Hidradenitis Suppurativa

Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
Logo
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine

See how precision biologics—dupilumab, IL-13/IL-31 blockers, JAK inhibitors, and omalizumab—change treatment for atopic dermatitis and chronic spontaneous urticaria.

Shorts

View All Shorts
HS is a Marathon, Not a Sprint
0:15
HS is a Marathon, Not a Sprint
5 days ago
by
Martina Porter, MD
Don’t Be Rash: Fighting for Life-Changing HS Therapies in Pediatrics
1:14
Don’t Be Rash: Fighting for Life-Changing HS Therapies in Pediatrics
3 months ago
by
Jillian Rork, MD(+1 more)
Steven Daveluy, MD
0:30
HS Breakthrough Excitement at AAD 2026
4 months ago
by
Steven Daveluy, MD

Podcasts

View More
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
The Cutaneous Connection: Rebuilding the Extracellular Matrix in Wound Healing and Aesthetics
The Cutaneous Connection: Rebuilding the Extracellular Matrix in Wound Healing and Aesthetics
Probiotics in Hidradenitis Suppurativa: Biologic Rationale vs. Clinical Evidence
Probiotics in Hidradenitis Suppurativa: Biologic Rationale vs. Clinical Evidence
The Cutaneous Connection: New ICD-10 Code Offers Validation for Patients With Topical Steroid Withdrawal
The Cutaneous Connection: New ICD-10 Code Offers Validation for Patients With Topical Steroid Withdrawal
The Cutaneous Connection: Representation, Education, and Revolutionizing Sunscreen for Skin of Color
The Cutaneous Connection: Representation, Education, and Revolutionizing Sunscreen for Skin of Color
New Immune-Mediated Therapies in AD, Alopecia Areata, and HS Presented at SDNP
New Immune-Mediated Therapies in AD, Alopecia Areata, and HS Presented at SDNP
Financial Toxicity Linked to Worse Quality of Life in HS
Financial Toxicity Linked to Worse Quality of Life in HS
Don't Be Rash: Rethinking Skin Disease in Down Syndrome
Don't Be Rash: Rethinking Skin Disease in Down Syndrome
The Cutaneous Connection: Debunking Allergy Myths and the Future of Atopic Dermatitis Treatment
The Cutaneous Connection: Debunking Allergy Myths and the Future of Atopic Dermatitis Treatment
The Cutaneous Connection: Diving Into the Safety and Efficacy of Icotrokinra, the New Oral IL-23 Peptide in Psoriasis
The Cutaneous Connection: Diving Into the Safety and Efficacy of Icotrokinra, the New Oral IL-23 Peptide in Psoriasis

Continuing Medical Education

View More
Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches
Video

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

View more
Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care
Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

View more
Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes
Adaptive Learning

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Corey Cutler, MD, MPH, FRCP(C); Amin M. Alousi, MD; Mehdi Hamadani, MD; Anna Sureda, MD, PhD

View more

All News